BNTC 8-K 2026-10-28

Benitec Biopharma Inc. (BNTC) 8-K dated 2026-10-28 — accession 0001193125-26-435159.

Benitec Biopharma Inc. (BNTC) is a biotechnology company listed on NASDAQ.

Benitec Biopharma Inc. filed a 8-K on 2026-10-28. Accession 0001193125-26-435159.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BNTC revenue for 2026-03-31 was $0. Net income was -$11.9M. BNTC currently screens at market cap $388.7M.

Not investment advice. The BNTC SEC hub lists recent forms. The stock page is the research view.